Top Biotechnology & Medical Research stocks in North America

Researchers and developers of biotechnology based drugs and therapies as well as medical devices and procedures that are at an early (non-commercial) stage.

Name
Market Cap
Price to Earnings
TTM
Dividend Yield
% TTM
us flag iconPCVXVaxcyte$8.88bnn/an/a
us flag iconIMGNImmunoGen$8.72bnn/an/a
us flag iconEXASExact Sciences$8.64bnn/an/a
us flag iconCERECerevel Therapeutics Holdings$7.82bnn/an/a
us flag iconRVMDRevolution Medicines$7.61bnn/an/a
us flag iconBPMCBlueprint Medicines$7.20bnn/an/a
us flag iconIONSIonis Pharmaceuticals$6.98bnn/an/a
us flag iconHALOHalozyme Therapeutics$6.88bn22.22n/a
us flag iconTEMTempus AI$6.82bnn/an/a
us flag iconEXELExelixis$6.58bn31.04n/a
us flag iconCYTKCytokinetics$6.55bnn/an/a
us flag iconRETAReata Pharmaceuticals$6.52bnn/an/a
us flag iconSMMTSummit Therapeutics$6.17bnn/an/a
us flag iconMDGLMadrigal Pharmaceuticals$6.12bnn/an/a
us flag iconKRYSKrystal Biotech$5.82bnn/an/a
us flag iconVKTXViking Therapeutics$5.61bnn/an/a
us flag iconISEEIVERIC bio$5.51bnn/an/a
us flag iconNUVLNuvalent$5.10bnn/an/a
us flag iconCRSPCrispr Therapeutics AG$4.63bnn/an/a
us flag iconSYNHSyneos Health$4.46bn28.55n/a